Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy… (Abstract)

Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy: Descriptive Review of a Rare Condition Clin Colon Rectal Surg 10 August 2022 https://pubmed.ncbi.nlm.nih.gov/35966977/ Mesenteric panniculitis (MP) is the preferred nomenclature for a continuum of inflammatory diseases of the mesentery. The diagnosis of MP is often based on the appearance of a mass-like structure at the root of […]

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia… (Abstract)

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial Braz J Anesthesiol 18 August 2022 https://pubmed.ncbi.nlm.nih.gov/35988815/ Introduction: Fibromyalgia is a complex, generalized, and diffuse chronic musculoskeletal pain. Pharmacological approaches are widely used to relieve pain and increase quality of life. Low-Dose Naltrexone (LDN) was shown to increase […]

Low-dose naltrexone for treatment of burning mouth syndrome (Abstract)

Low-dose naltrexone for treatment of burning mouth syndrome Oral Surg Oral Med Oral Pathol Oral Radiol 30 April 2022 https://pubmed.ncbi.nlm.nih.gov/35851249/ Objective: The International Classification of Disease defines burning mouth syndrome (BMS) as a chronic intraoral burning sensation, with no identifiable local or systemic cause. Since current management is often unsatisfactory, the aim of this report […]

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study (Abstract)

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study Brain Behav Immun Health 03 July 2022 https://www.sciencedirect.com/science/article/pii/S2666354622000758 Background: Up to 37.7% of patients experience symptoms beyond 12 weeks after infection with SARS-CoV-2. To date care for people with long covid has centred around multidisciplinary rehabilitation, self care and […]

Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone (Abstract)

Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone J Clin Aesthet Dermatol November 2020 https://www.academia.edu/79471188/Recalcitrant_Hailey_Hailey_Disease_Successfully_Treated_with_Low_dose_Naltrexone?email_work_card=title Hailey-Hailey (HHD), or benign familial chronic pemphigus disease, is a rare autosomal dominant blistering disorder characterized by recurrent vesicles that erode and macerate into weeping and crusting plaques. HHD has been shown to be resistant to several treatment options. Although […]

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project (Abstract)

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project IOS Press Content Library 04 July 2022 https://content.iospress.com/articles/journal-of-alzheimers-disease/jad215707 Background: Effective therapeutics for Alzheimer’s disease are needed. However, previous clinical trials have pre-determined a single treatment modality, such as a drug candidate or therapeutic procedure, which may be unrelated to the primary drivers of the neurodegenerative process. Therefore, […]

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS (Abstract)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS Neurol Neuroimmunol Neuroinflamm 01 Oct 2014 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204226/#:~:text=Advocates%20of%20LDN%20use%20have,increased%20risk%20of%20developing%20ITP Naltrexone is an opiate µ-receptor antagonist approved for treatment of alcohol dependency at a recommended dose of 50 mg/day. The mechanism of action is proposed to be mediated by a normalization of endogenous endorphin levels. […]

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer… (Abstract)

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients Oncol Lett 07 June 2022 https://pubmed.ncbi.nlm.nih.gov/35761946/ Cancer is associated with chronic inflammation and disruption to normal immune function. As such, the ability to thrive in a chronically inflamed microenvironment is regarded as a hallmark of […]

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction? (Abstract)

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction? Curr Oncol Rep 01 June 2022 https://pubmed.ncbi.nlm.nih.gov/35648340/ Purpose of review: Antagonists of mu-opioid receptor role in cancer progression remains to be elucidated. The objective of this review was to summarize the available evidence on antagonists of mu-opioid receptor effect on tumor progression and […]